Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK13 | O15264 | 1/20 | 0.35 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.35 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 6/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 5/20 | 0.33 |
| ▸ | SLC2A3 | P11169 | 5/20 | 0.33 |
| ▸ | SLC2A4 | P14672 | 5/20 | 0.33 |
| ▸ | SLC2A2 | P11168 | 3/20 | 0.33 |
| ▸ | CD38 | P28907 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13085589 | 0.94 | SLC2A1 (0.33) | NTRK1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL13085388 | 0.92 | GAA (0.34) | MAPK13MAPK12MAPK11MAPK14NTRK1 | |
| SCHEMBL13085386 | 0.92 | MAPK13 (0.34) | MAPK13MAPK12MAPK11MAPK14NTRK1 | |
| SCHEMBL13085462 | 0.92 | MAPK13 (0.36) | MAPK13MAPK12MAPK11MAPK14NTRK1 | |
| SCHEMBL13085389 | 0.91 | MAPK13 (0.34) | MAPK13MAPK12MAPK11MAPK14NTRK1 | |
| SCHEMBL13085382 | 0.90 | MAPK13 (0.33) | MAPK13MAPK12MAPK11MAPK14NTRK1 | |
| SCHEMBL13085483 | 0.87 | SLC2A1 (0.34) | NTRK1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL13085608 | 0.87 | SLC2A1 (0.32) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL13085270 | 0.86 | MAPK14 (0.34) | MAPK13MAPK12MAPK11MAPK14NTRK1 | |
| SCHEMBL13085624 | 0.85 | SLC2A1 (0.30) | SLC2A1SLC2A3SLC2A4SLC2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324390-B2 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-12-04 | — | — | US | disclosed |
| US-8324390-B2 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-12-04 | — | — | US | disclosed |
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-07 | — | — | US | disclosed |
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | ANTXR2, PNISR, H1-5 | MAPK13 4357/4885MAPK12 3656/4885MAPK11 3780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.